Elicio Therapeutics Inc. (ELTX) — Cash Flow Reinvestment Rate
Elicio Therapeutics Inc. (ELTX) has a Cash Flow Reinvestment Rate of 0.09x as of June 2022, reinvesting $559.00K (capex $559.00K ) from operating cash flow of $6.14 Million. See ELTX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Elicio Therapeutics Inc. Cash Flow Reinvestment Rate (2012–2013)
Historical reinvestment intensity for Elicio Therapeutics Inc. across 2 annual periods. For the full cash flow conversion analysis, see ELTX cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Elicio Therapeutics Inc. (2012–2013)
Year-by-year capital reinvestment analysis for Elicio Therapeutics Inc.. See ELTX financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2013 | 0.01x | $17.57K | $1.89 Million | $17.57K | ▼ -79.3% |
| 2012 | 0.04x | $47.73K | $1.07 Million | $47.73K | — |